Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention.
Kisalu NK, Pereira LD, Ernste K, Flores-Garcia Y, Idris AH, Asokan M, Dillon M, MacDonald S, Shi W, Chen X, Pegu A, Schön A, Zavala F, Balazs AB, Francica JR, Seder RA.
Kisalu NK, et al.
JCI Insight. 2021 Feb 8;6(3):e143958. doi: 10.1172/jci.insight.143958.
JCI Insight. 2021.
PMID: 33332286
Free PMC article.